Transcranial Electromagnetic Treatment (TEMT) Against Alzheimer's Disease
Phase 1
- Conditions
- Alzheimer's Disease
- First Posted Date
- 2020-02-17
- Last Posted Date
- 2020-02-17
- Lead Sponsor
- NeuroEM Therapeutics, Inc.
- Target Recruit Count
- 6
- Registration Number
- NCT04271163
- Locations
- 🇺🇸
Axiom Clinical Research of Florida, Tampa, Florida, United States
Transcranial Electromagnetic Treatment Against Alzheimer's Disease
Not Applicable
- Conditions
- Alzheimer DiseaseAlzheimer Disease, Late Onset
- Interventions
- Device: MemorEM 1000
- First Posted Date
- 2019-04-25
- Last Posted Date
- 2020-02-26
- Lead Sponsor
- NeuroEM Therapeutics, Inc.
- Target Recruit Count
- 7
- Registration Number
- NCT03927040
- Locations
- 🇺🇸
Byrd Alzheimer's Institute, University of South Florida, Tampa, Florida, United States
Safety and Efficacy of Transcranial Electromagnetic Treatment Against Alzheimer's Disease
Not Applicable
Completed
- Conditions
- Alzheimer Disease, Late OnsetAlzheimer Disease
- Interventions
- Device: MemorEM 1000
- First Posted Date
- 2016-11-08
- Last Posted Date
- 2019-04-23
- Lead Sponsor
- NeuroEM Therapeutics, Inc.
- Target Recruit Count
- 8
- Registration Number
- NCT02958930
- Locations
- 🇺🇸
Byrd Alzheimer's Institute, University of South Florida, Tampa, Florida, United States
© Copyright 2025. All Rights Reserved by MedPath